Corrigan Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-2,680
| Closed | -$361K | – | 38 |
|
2023
Q2 | $361K | Buy |
2,680
+2
| +0.1% | +$269 | 0.11% | 53 |
|
2023
Q1 | $427K | Sell |
2,678
-124
| -4% | -$19.8K | 0.14% | 45 |
|
2022
Q4 | $453K | Buy |
2,802
+3
| +0.1% | +$485 | 0.17% | 43 |
|
2022
Q3 | $376K | Buy |
2,799
+4
| +0.1% | +$537 | 0.14% | 49 |
|
2022
Q2 | $428K | Sell |
2,795
-998
| -26% | -$153K | 0.16% | 47 |
|
2022
Q1 | $615K | Buy |
3,793
+941
| +33% | +$153K | 0.19% | 41 |
|
2021
Q4 | $386K | Sell |
2,852
-184
| -6% | -$24.9K | 0.11% | 55 |
|
2021
Q3 | $327K | Hold |
3,036
| – | – | 0.1% | 58 |
|
2021
Q2 | $342K | Sell |
3,036
-175
| -5% | -$19.7K | 0.1% | 57 |
|
2021
Q1 | $348K | Buy |
3,211
+2
| +0.1% | +$216 | 0.12% | 54 |
|
2020
Q4 | $344K | Buy |
3,209
+2
| +0.1% | +$214 | 0.15% | 46 |
|
2020
Q3 | $281K | Sell |
3,207
-848
| -21% | -$74.3K | 0.14% | 47 |
|
2020
Q2 | $398K | Buy |
4,055
+2
| +0% | +$196 | 0.21% | 33 |
|
2020
Q1 | $309K | Sell |
4,053
-1
| -0% | -$76 | 0.23% | 38 |
|
2019
Q4 | $359K | Buy |
4,054
+5
| +0.1% | +$443 | 0.25% | 36 |
|
2019
Q3 | $307K | Buy |
4,049
+3
| +0.1% | +$227 | 0.23% | 38 |
|
2019
Q2 | $294K | Sell |
4,046
-598
| -13% | -$43.5K | 0.22% | 40 |
|
2019
Q1 | $374K | Buy |
4,644
+1,600
| +53% | +$129K | 0.27% | 37 |
|
2018
Q4 | $281K | Buy |
3,044
+2
| +0.1% | +$184 | 0.23% | 34 |
|
2018
Q3 | $288K | Sell |
3,042
-390
| -11% | -$36.9K | 0.21% | 33 |
|
2018
Q2 | $318K | Buy |
3,432
+2
| +0.1% | +$185 | 0.24% | 30 |
|
2018
Q1 | $325K | Buy |
3,430
+251
| +8% | +$23.8K | 0.25% | 28 |
|
2017
Q4 | $307K | Sell |
3,179
-22
| -0.7% | -$2.13K | 0.26% | 30 |
|
2017
Q3 | $284K | Sell |
3,201
-147
| -4% | -$13.1K | 0.25% | 35 |
|
2017
Q2 | $243K | Buy |
+3,348
| New | +$243K | 0.23% | 37 |
|